E&C Exempts Nursing Homes, Hospice & Others From Pharmacy Lock-In
At the urging of seniors’ advocates and long-term care pharmacies, House Energy & Commerce members tweaked the pharmacy lock-in measure in the latest version of their Cures bill to exempt patients in nursing homes, hospice, intermediate care facilities for the mentally retarded and facilities that contract with a single pharmacy to dispense frequently abused drugs.
The updated lock-in measure, which aims to curb prescription drug abuse, is part of 21st Century Cures legislation that the committee is scheduled to vote on Thursday (May 21).
The draft bill that the committee released just last week exempted hospice from the measure, but it left it to CMS’ discretion to exempt others, such as nursing homes. Long-term care pharmacies were pleased with the measure but continued lobbying for an outright exemption for nursing homes. The pharmacy lock-in measure has changed with each iteration of the Cures bill. The second draft added a beneficiary-appeals measure, but lobbyists for seniors and long-term care pharmacies said that was insufficient.
Seniors’ advocates and long-term care pharmacies support drug-abuse prevention, but they worry the pharmacy lock-in measure in the Cures bill would make it difficult for beneficiaries to obtain vital medicine.
Alan Rosenbloom, president of Senior Care Pharmacy Coalition, which represents independent long-term care pharmacies, said long-term care pharmacies already are subject to regulations stricter than those that would be applied to so-called safe pharmacy networks in the 21st Century Cures bill. — John Wilkerson (jwilkerson@iwpnews.com)
Click here to see the original article on the Inside Health Policy website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.